Point-of-Care Diagnostic Devices Market is expected to reach USD 88.8 billion by 2031

Point-of-Care Diagnostic Devices Market Trends & Forecast

According to a research study published by Knowledge Sourcing Intelligence (KSI), the point-of-care diagnostic devices market will expand from USD 48.4 billion in 2026 to USD 88.8 billion in 2031 at a CAGR of 12.9% during the forecast period.

The point-of-care (poc) diagnostic devices market is witnessing robust and constant growth due to the worldwide change towards decentralized healthcare, quick diagnosis, and patient-centric care models. POC devices, which allow patient testing at or near the point of care, such as clinics, physician offices, pharmacies, and even homes, are being preferred far more than the traditional laboratory-based diagnostics mainly because they can provide results faster, they are more convenient, and they have the capability to deliver real-time clinical decision support. The market includes a variety of technologies like glucose monitoring systems, infectious disease testing kits, cardiac biomarkers, blood gas analyzers, pregnancy and fertility tests, and advanced molecular diagnostics platforms.

Request a free sample copy or view the report summary: Point-of-Care Diagnostic Devices Market Report

Point-of-Care Diagnostic Devices Market Report Highlights

• The infectious disease testing instruments are the segment witnessing the fastest growth because of the increasing incidence of diseases such as COVID-19, influenza, HIV, and tuberculosis, as well as the need for rapid and early diagnosis. These instruments yield quick and accurate results at the point of care, which is useful for making decisions about treatment on time and minimizing the spread of the disease. Constant innovation in rapid test kits and portable diagnostic devices is boosting this segment's growth as well.

• Molecular diagnostics is the fastest-growing segment because of its highly accurate, sensitive, and early detection capability of diseases. The rising use of PCR and other nucleic acid amplification methods in point-of-care situations, mainly for the identification of infectious diseases, is the main driver of demand. Besides, the development of compact and easy-to-use molecular instruments helps the growth of this market.

• The growing preference for self-testing and remote patient monitoring is making home care settings the fastest-growing segment of application. Diagnostic kits that are easy to use, cost-effective, and readily available have made it possible for patients to perform tests at home. Besides, the shift toward patient-centric healthcare models, telehealth integration, and increased awareness are helping to support the trend.

• The Asia-Pacific region is the fastest-growing market for point-of-care diagnostic devices, driven by a large patient population, rising prevalence of chronic and infectious diseases, and improving healthcare infrastructure.

Point-of-Care Diagnostic Devices Market Growth Drivers and Restraints

Growth Drivers:

• Rising Prevalence of Chronic and Infectious Diseases: The rising worldwide incidence of diseases like diabetes, cardiovascular diseases, respiratory diseases, and infectious diseases is one of the main factors leading to the growth of the POC diagnostics market. These diseases necessitate regular and quick testing, which POC devices make possible directly at the patient's site, thereby enhancing the management of the disease and the quality of the patient's life.

• Growing Demand for Rapid and Real-Time Diagnostics: Healthcare systems worldwide are changing their focus to quick clinical decision-making. Point-of-care devices offer instant results, which leads to a shorter turnaround time when compared to central laboratories. This is very important in emergency care, intensive care, and infectious disease control.

Restraints:

• Stringent Regulatory Requirements: The POC diagnostic devices should meet stringent regulatory standards to guarantee safety and effectiveness. Obtaining approval usually involves lengthy and expensive procedures, which may even delay the launch of the products and hinder market entry for newcomers.

Point-of-Care Diagnostic Devices Market Key Development

• Collaboration: In August 2025, the Technology Development Board (TDB), a Government of India department under the Ministry of Science and Technology, entered into a collaboration with M/s Primary Healthtech Pvt. Ltd., New Delhi, for the project "IoT-enabled Point-of-care Blood Testing Device for Affordable and Accessible Healthcare powered by AI/ML algorithms."

• Product Launch: In June 2025, Royal Philips, a health technology company with a strong global presence, introduced the Flash Ultrasound System 5100 POC worldwide. This is a point-of-care (POC) ultrasound system designed to meet the rapidly evolving requirements of anesthesia, critical care, emergency medicine, and musculoskeletal imaging.

Point-of-Care Diagnostic Devices Market Segmentation

Knowledge Sourcing Intelligence has segmented the point-of-care diagnostic devices market based on product type, technology, application, and region:

Point-of-Care Diagnostic Devices Market, By Product Type

• Glucose Monitoring Devices

• Infectious Disease Testing Devices

• Cardiac Marker Testing Devices

• Blood Gas & Electrolyte Analysers

• Pregnancy & Fertility Testing Devices

Point-of-Care Diagnostic Devices Market, By Technology

• Lateral Flow Assays

• Immunoassays

• Molecular Diagnostics

• Microfluidics

Point-of-Care Diagnostic Devices Market, By Application

• Hospitals & Clinics

• Diagnostic Laboratories

• Home Care Settings

• Ambulatory Care Centers

Point-of-Care Diagnostic Devices Market, By Region

• North America

  • USA

  • Canada

  • Mexico

• Europe

  • United Kingdom

  • Germany

  • France

  • Spain

  • Others

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Indonesia

  • Thailand

  • Others

• South America

  • Brazil

  • Argentina

  • Others

• Middle East and Africa (MEA)

  • Saudi Arabia

  • UAE

  • Others

Point-of-Care Diagnostic Devices Market Key Players

• Abbott Laboratories

• Roche Diagnostics

• Siemens Healthineers

• Thermo Fisher Scientific

• Becton Dickinson and Company

• QuidelOrtho Corporation

• Everlywell

• LetsGetChecked

• OraSure Technologies

• Cue Health